The sweet spot: How gags help chemokines guide migrating cells

Journal of Leukocyte Biology

Volumn 99, Issue 6, 2016, Pages 935-953

  Monneau, Yoan ^a,b,c   Arenzana Seisdedos, Fernando ^d   Lortat Jacob, Hugues ^a,b,c  

^a UNIV GRENOBLE ALPES   (France)

^b CNRS   (France)

^c DIF   (France)

^d INSERM   (France)

Author keywords

Chemokine receptor; Heparan sulfate; Structure function relationships

Indexed keywords

CHEMOKINE; GLYCOSAMINOGLYCAN; HEPARIN; LIGAND;

BINDING SITE; CELL MIGRATION; CHEMICAL STRUCTURE; CHEMOTAXIS; COMPLEX FORMATION; EPIMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; AMINO ACID SEQUENCE; ANIMAL; CELL MOTION; CHEMISTRY; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL MOVEMENT; CHEMOKINES; GLYCOSAMINOGLYCANS; HUMANS; LIGANDS; SIGNAL TRANSDUCTION;

EID: 84971441746     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3MR0915-440R     Document Type: Review

References (167)

1. Francis, K., Palsson, B. O. (1997) Effective intercellular communication distances are determined by the relative time constants for cyto/chemokine secretion and diffusion. Proc. Natl. Acad. Sci. U. S. A. 94, 12258-12262.
2. Nathan, C., Sporn, M. (1991) Cytokines in context. J. Cell Biol. 113, 981-986.
3. Bishop, J. R., Schuksz, M., Esko, J. D. (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030-1037.
4. Iozzo, R. V., Schaefer, L. (2015) Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol. 42, 11-55.
5. Coombe, D. R. (2008) Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. Immunol. Cell Biol. 86, 598-607.
6. Lindahl, U., Li, J. P. (2009) Interactions between heparan sulfate and proteins-design and functional implications. Int. Rev. Cell Mol. Biol. 276, 105-159.
7. Sarrazin, S., Lamanna, W. C., Esko, J. D. (2011) Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 3, a004952.
8. Belov, A. A., Mohammadi, M. (2013) Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology. Cold Spring Harb. Perspect. Biol. 5, a015958.
9. Jastrebova, N., Vanwildemeersch, M., Lindahl, U., Spillmann, D. (2010) Heparan sulfate domain organization and sulfation modulate FGFinduced cell signaling. J. Biol. Chem. 285, 26842-26851.
10. Pye, D. A., Vivès, R. R., Hyde, P., Gallagher, J. T. (2000) Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2. Glycobiology 10, 1183-1192.
11. Lian, J., Luster, A. D. (2015) Chemokine-guided cell positioning in the lymph node orchestrates the generation ofadaptive immune responses. Curr. Opin. Cell Biol. 36, 1-6.
12. Zlotnik, A., Yoshie, O. (2012) The chemokine superfamily revisited. Immunity 36, 705-716.
13. LortatJacob, H., Grosdidier, A., Imberty, A. (2002) Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl. Acad. Sci. U. S. A. 99, 1229-1234.
14. Bao, X., Moseman, E. A., Saito, H., Petryniak, B., Thiriot, A., Hatakeyama, S., Ito, Y., Kawashima, H., Yamaguchi, Y., Lowe, J. B., von Andrian, U. H., Fukuda, M. (2010) Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes [published correction in Immunity (2011) 34:820]. Immunity 33, 817-829.
15. Massena, S., Christoffersson, G., Hjertstrom, E., Zcharia, E., Vlodavsky, I., Ausmees, N., Rolny, C., Li, J. P., Phillipson, M. (2010) A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils. Blood 116, 1924-1931.
16. Proudfoot, A. E., Handel, T. M., Johnson, Z., Lau, E. K., LiWang, P., Clark-Lewis, I., Borlat, F., Wells, T. N. C., Kosco-Vilbois, M. H. (2003) Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U. S. A. 110, 1885-1890.
17. Rueda, P., Balabanian, K., Lagane, B., Staropoli, I., Chow, K., Levoye, A., Laguri, C., Sadir, R., Delaunay, T., Izquierdo, E., Pablos, J. L., Lendinez, E., Caruz, A., Franco, D., Baleux, F., LortatJacob, H., Arenzana-Seisdedos, F. (2008) The CXCL12g chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. PLoS One 3, e2543.
18. Rueda, P., Richart, A., Recalde, A., Gasse, P., Vilar, J., Guerin, C., Lortat-Jacob, H., Vieira, P., Baleux, F., Chretien, F., Arenzana-Seisdedos, F., Silvestre, J. S. (2012) Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions. Circulation 126, 1882-1895.
19. Salanga, C. L., Handel, T. M. (2011) Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp. Cell Res. 317, 590-601.
20. Gallagher, J. T., Walker, A. (1985) Molecular distinctions between heparan sulphate and heparin: analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families ofN-sulphated polysaccharides. Biochem. J. 230, 665-674.
21. Khan, S., Fung, K. W., Rodriguez, E., Patel, R., Gor, J., Mulloy, B., Perkins, S. J. (2013) The solution structure of heparan sulfate differs from that of heparin: implications for function. J. Biol. Chem. 288, 27737-27751.
22. Gallagher, J. (2015) Fell-Muir lecture: heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra. Int. J. Exp. Pathol. 96, 203-231.
23. Grifith, J. W., Sokol, C. L., Luster, A. D. (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu. Rev. Immunol. 32, 659-702.
24. Moser, B., Willimann, K. (2004) Chemokines: role in inflammation and immune surveillance. Ann. Rheum. Dis. 63(Suppl 2), 284-289.
25. Graham, G. J., Locati, M., Mantovani, A., Rot, A., Thelen, M. (2012) The biochemistry and biology ofthe atypical chemokine receptors. Immunol. Lett. 145, 30-38.
26. Stephens, B., Handel, T. M. (2013) Chemokine receptor oligomerization and allostery. Prog. Mol. Biol. Transl. Sci. 115, 375-420.
27. Clark-Lewis, I., Schumacher, C., Baggiolini, M., Moser, B. (1991) Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J. Biol. Chem. 266, 23128-23134.
28. Crump, M. P., Gong, J. H., Loetscher, P., Rajarathnam, K., Amara, A., Arenzana-Seisdedos, F., Virelizier, J. L., Baggiolini, M., Sykes, B. D., Clark-Lewis, I. (1997) Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16, 6996-7007.
29. Kufareva, I., Stephens, B. S., Holden, L. G., Qin, L., Zhao, C., Kawamura, T., Abagyan, R., Handel, T. M. (2014) Stoichiometry and geometry of the CXC chemokine receptor 4 complex with CXC ligand 12: molecular modeling and experimental validation. Proc. Natl. Acad. Sci. U.S.A. 111, E5363-E5372.
30. Millard, C. J., Ludeman, J. P., Canals, M., Bridgford, J. L., Hinds, M. G., Clayton, D. J., Christopoulos, A., Payne, R. J., Stone, M. J. (2014) Structural basis of receptor sulfotyrosine recognition by a CC chemokine: the N-terminal region ofCCR3 bound to CCL11/eotaxin-1. Structure 22, 1571-1581.
31. Skelton, N.J., Quan, C., Reilly, D., Lowman, H. (1999) Structure of a CXC chemokine-receptor fragment in complex with interleukin-8. Structure 7, 157-168.
32. Veldkamp, C. T., Seibert, C., Peterson, F. C., De la Cruz, N. B., Haugner, J. C., Basnet, H., Sakmar, T. P., Volkman, B. F. (2008) Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/ CXCL12. Sci. Signal. 1-4.
33. Kofuku, Y., Yoshiura, C., Ueda, T., Terasawa, H., Hirai, T., Tominaga, S., Hirose, M., Maeda, Y., Takahashi, H., Terashima, Y., Matsushima, K., Shimada, I. (2009) Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-proteincoupled receptor CXCR4. J. Biol. Chem. 284, 35240-35250.
34. Yoshiura, C., Kofuku, Y., Ueda, T., Mase, Y., Yokogawa, M., Osawa, M., Terashima, Y., Matsushima, K., Shimada, I. (2010) NMR analyses of the interaction between CCR5 and its ligand using functional reconstitution of CCR5 in lipid bilayers. J. Am. Chem. Soc. 132, 6768-6777.
35. Ludeman, J. P., Stone, M. J. (2014) The structural role of receptor tyrosine sulfation in chemokine recognition. Br. J. Pharmacol. 171, 1167-1179.
36. Hileman, R. E., Fromm, J. R., Weiler, J. M., Linhardt, R. J. (1998) Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20, 156-167.
37. Sarkar, A., Desai, U. R. (2015) A simple method for discovering druggable, specific glycosaminoglycan-protein systems: elucidation of key principles from heparin/heparan sulfate-binding proteins. PLoS One 10, e0141127.
38. Poluri, K. M., Joseph, P. R., Sawant, K. V., Rajarathnam, K. (2013) Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer. J. Biol. Chem. 288, 25143-25153.
39. Rajasekaran, D., Keeler, C., Syed, M. A., Jones, M. C., Harrison, J. K., Wu, D., Bhandari, V., Hodsdon, M. E., Lolis, E. J. (2012) A model of GAG/MIP-2/CXCR2 interfaces and its functional effects. Biochemistry 51, 5642-5654.
40. Mayo, K. H., Ilyina, E., Roongta, V., Dundas, M., Joseph, J., Lai, C. K., Maione, T., Daly, T. J. (1995) Heparin binding to platelet factor-4—an NMR and site-directed mutagenesis study: arginine residues are crucial for binding. Biochem. J. 312, 357-365.
41. Kuschert, G. S., Hoogewerf, A. J., Proudfoot, A. E., Chung, C. W., Cooke, R. M., Hubbard, R. E., Wells, T. N., Sanderson, P. N. (1998) Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 37, 11193-11201.
42. Campanella, G. S., Lee, E. M., Sun, J., Luster, A. D. (2003) CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). J. Biol. Chem. 278, 17066-17074.
43. Severin, I. C., Gaudry, J. P., Johnson, Z., Kungl, A., Jansma, A., Gesslbauer, B., Mulloy, B., Power, C., Proudfoot, A. E., Handel, T. (2010) Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans. J. Biol. Chem. 285, 17713-17724.
44. Peterson, F. C., Elgin, E. S., Nelson, T. J., Zhang, F., Hoeger, T. J., Linhardt, R. J., Volkman, B. F. (2004) Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin. J. Biol. Chem. 279, 12598-12604.
45. Amara, A., Lorthioir, O., Valenzuela, A., Magerus, A., Thelen, M., Montes, M., Virelizier, J. L., Delepierre, M., Baleux, F., Lortat-Jacob, H., Arenzana-Seisdedos, F. (1999) Stromal cell-derived factor-1a associates with heparan sulfates through the first b-strand of the chemokine. J. Biol. Chem. 274, 23916-23925.
46. Laguri, C., Sadir, R., Rueda, P., Baleux, F., Gans, P., Arenzana-Seisdedos, F., Lortat-Jacob, H. (2007) The novel CXCL12g isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. PLoS One 2, e1110.
47. Sadir, R., Baleux, F., Grosdidier, A., Imberty, A., Lortat-Jacob, H. (2001) Characterization of the stromal cell-derived factor-1a-heparin complex. J. Biol. Chem. 276, 8288-8296.
48. Koopmann, W., Krangel, M. S. (1997) Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1a. J. Biol. Chem. 272, 10103-10109.
49. Laurence, J. S., Blanpain, C., De Leener, A., Parmentier, M., LiWang, P. J. (2001) Importance of basic residues and quaternary structure in the function of MIP-1b: CCR5 binding and cell surface sugar interactions. Biochemistry 40, 4990-4999.
50. Proudfoot, A. E., Fritchley, S., Borlat, F., Shaw, J. P., Vilbois, F., Zwahlen, C., Trkola, A., Marchant, D., Clapham, P. R., Wells, T. N. (2001) The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276, 10620-10626.
51. Gupta, S., Rieder, S., Richter, R., Schulz-Maronde, S., Manns, J., Escher, S. E., Heitland, A., Mack, M., Forssmann, W. G., Elsner, J., Forssmann, U. (2010) CCR1- and CCR5-mediated inactivation of leukocytes by a nonglycosaminoglycan (non-GAG)-binding variant of n-nonanoyl-CCL14 (NNY-CCL14). J. Leukoc. Biol. 88, 383-392.
52. Krohn, S. C., Bonvin, P., Proudfoot, A. E. (2013) CCL18 exhibits a regulatory role through inhibition of receptor and glycosaminoglycan binding. PLoS One 8, e72321.
53. Lau, E. K., Paavola, C. D., Johnson, Z., Gaudry, J. P., Geretti, E., Borlat, F., Kungl, A. J., Proudfoot, A. E., Handel, T. M. (2004) Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J. Biol. Chem. 279, 22294-22305.
54. Salanga, C. L., Dyer, D. P., Kiselar, J. G., Gupta, S., Chance, M. R., Handel, T. M. (2014) Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine. J. Biol. Chem. 289, 14896-14912.
55. Chakravarty, L., Rogers, L., Quach, T., Breckenridge, S., Kolattukudy, P. E. (1998) Lysine 58 and histidine 66 at the C-terminal a-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. J. Biol. Chem. 273, 29641-29647.
56. Hoover, D. M., Mizoue, L. S., Handel, T. M., Lubkowski, J. (2000) The crystal structure of the chemokine domain of fractalkine shows a novel quaternary arrangement. J. Biol. Chem. 275, 23187-23193.
57. Vanheule, V., Janssens, R., Boff, D., Kitic, N., Berghmans, N., Ronsse, I., Kungl, A. J., Amaral, F. A., Teixeira, M. M., Van Damme, J., Proost, P., Mortier, A. (2015) The positively charged COOH-terminal glycosaminoglycan binding CXCL9(74-103) peptide inhibits CXCL8-induced neutrophil extravasation and monosodium urate crystalinduced gout in mice. J. Biol. Chem. 290, 21292-21304.
58. Schumann, K., Lämmermann, T., Bruckner, M., Legler, D. F., Polleux, J., Spatz, J. P., Schuler, G., Förster, R., Lutz, M. B., Sorokin, L., Sixt, M. (2010) Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 32, 703-713.
59. Preobrazhensky, A. A., Dragan, S., Kawano, T., Gavrilin, M. A., Gulina, I. V., Chakravarty, L., Kolattukudy, P. E. (2000) Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region. J. Immunol. 165, 5295-5303.
60. Tan, J. H., Ludeman, J. P., Wedderburn, J., Canals, M., Hall, P., Butler, S. J., Taleski, D., Christopoulos, A., Hickey, M. J., Payne, R. J., Stone, M. J. (2013) Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1). J. Biol. Chem. 288, 10024-10034.
61. Farzan, M., Mirzabekov, T., Kolchinsky, P., Wyatt, R., Cayabyab, M., Gerard, N. P., Gerard, C., Sodroski, J., Choe, H. (1999) Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96, 667-676.
62. Gutièrrez, J., Kremer, L., Zaballos, A., Goya, I., Martìnez, C., Márquez, G. (2004) Analysis of post-translational CCR8 modifications and their influence on receptor activity. J. Biol. Chem. 279, 14726-14733.
63. Colvin, R. A., Campanella, G. S., Manice, L. A., Luster, A. D. (2006) CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis. Mol. Cell. Biol. 26, 5838-5849.
64. Farzan, M., Babcock, G. J., Vasilieva, N., Wright, P. L., Kiprilov, E., Mirzabekov, T., Choe, H. (2002) The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry. J. Biol. Chem. 277, 29484-29489.
65. Fong, A. M., Alam, S. M., Imai, T., Haribabu, B., Patel, D. D. (2002) CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion. J. Biol. Chem. 277, 19418-19423.
66. Choe, H., Moore, M. J., Owens, C. M., Wright, P. L., Vasilieva, N., Li, W., Singh, A. P., Shakri, R., Chitnis, C. E., Farzan, M. (2005) Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Mol. Microbiol. 55, 1413-1422.
67. Maynard, H. D., Hubbell, J. A. (2005) Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor. Acta Biomater. 1, 451-459.
68. Connell, B. J., Baleux, F., Coic, Y. M., Clayette, P., Bonnaffè, D., Lortat-Jacob, H. (2012) A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage. Chem. Biol. 19, 131-139.
69. Safaiyan, F., Kolset, S. O., Prydz, K., Gottfridsson, E., Lindahl, U., Salmivirta, M. (1999) Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J. Biol. Chem. 274, 36267-36273.
70. Jen, C. H., Leary, J. A. (2010) A competitive binding study of chemokine, sulfated receptor, and glycosaminoglycan interactions by nano-electrospray ionization mass spectrometry. Anal. Biochem. 407, 134-140.
71. Duma, L., Häussinger, D., Rogowski, M., Lusso, P., Grzesiek, S. (2007) Recognition of RANTES by extracellular parts of the CCR5 receptor. J. Mol. Biol. 365, 1063-1075.
72. Ziarek, J. J., Getschman, A. E., Butler, S. J., Taleski, D., Stephens, B., Kufareva, I., Handel, T. M., Payne, R. J., Volkman, B. F. (2013) Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomerspecific contacts and chemokine allostery. ACS Chem. Biol. 8, 1955-1963.
73. Kuschert, G. S., Coulin, F., Power, C. A., Proudfoot, A. E., Hubbard, R. E., Hoogewerf, A. J., Wells, T. N. (1999) Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38, 12959-12968.
74. Fermas, S., Gonnet, F., Sutton, A., Charnaux, N., Mulloy, B., Du, Y., Baleux, F., Daniel, R. (2008) Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis. Glycobiology 18, 1054-1064.
75. Krieger, E., Geretti, E., Brandner, B., Goger, B., Wells, T. N., Kungl, A. J. (2004) A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations. Proteins 54, 768-775.
76. Mizumoto, S., Fongmoon, D., Sugahara, K. (2013) Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines. Glycoconj. J. 30, 619-632.
77. Przybylski, C., Gonnet, F., Hersant, Y., Bonnaffè, D., Lortat-Jacob, H., Daniel, R. (2010) Desorption electrospray ionization mass spectrometry of glycosaminoglycans and their protein noncovalent complex. Anal. Chem. 82, 9225-9233.
78. Seo, Y., Andaya, A., Bleiholder, C., Leary, J. A. (2013) Differentiation of CC vs CXC chemokine dimers with GAG octasaccharide binding partners: an ion mobility mass spectrometry approach. J. Am. Chem. Soc. 135, 4325-4332.
79. Pomin, V. H. (2014) Heparin-Binding Proteins (Chemokines and Defensins) and their complexes with glycosaminoglycans from the solution NMR perspective. Curr. Protein Pept. Sci. 15, 738-744.
80. Vivès, R. R., Sadir, R., Imberty, A., Rencurosi, A., Lortat-Jacob, H. (2002) A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41, 14779-14789.
81. Tanino, Y., Coombe, D. R., Gill, S. E., Kett, W. C., Kajikawa, O., Proudfoot, A. E., Wells, T. N., Parks, W. C., Wight, T. N., Martin, T. R., Frevert, C. W. (2010) Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs. J. Immunol. 184, 2677-2685.
82. Thakar, D., Migliorini, E., Coche-Guerente, L., Sadir, R., Lortat-Jacob, H., Boturyn, D., Renaudet, O., Labbe, P., Richter, R. P. (2014) A quartz crystal microbalance method to study the terminal functionalization of glycosaminoglycans. Chem. Commun. (Camb.) 50, 15148-15151.
83. Migliorini, E., Thakar, D., Sadir, R., Pleiner, T., Baleux, F., Lortat-Jacob, H., Coche-Guerente, L., Richter, R. P. (2014) Well-defined biomimetic surfaces to characterize glycosaminoglycan-mediated interactions on the molecular, supramolecular and cellular levels. Biomaterials 35, 8903-8915.
84. Iacob, R. E., Engen, J. R. (2012) Hydrogen exchange mass spectrometry: are we out of the quicksand? J. Am. Soc. Mass Spectrom. 23, 1003-1010.
85. Hofmann, T., Samsonov, S. A., Pichert, A., Lemmnitzer, K., Schiller, J., Huster, D., Pisabarro, M. T., von Bergen, M., Kalkhof, S. (2015) Structural analysis of the interleukin-8/glycosaminoglycan interactions by amide hydrogen/deuterium exchange mass spectrometry. Methods 89, 45-53.
86. Pomin, V. H., Mulloy, B. (2015) Current structural biology of the heparin interactome. Curr. Opin. Struct. Biol. 34, 17-25.
87. Chiu, L. Y., Hung, K. W., Tjong, S. C., Chiang, Y. W., Sue, S. C. (2014) NMR characterization of the electrostatic interaction of the basic residues in HDGF and FGF2 during heparin binding. Biochim. Biophys. Acta 1844, 1851-1859.
88. Möbius, K., Nordsieck, K., Pichert, A., Samsonov, S. A., Thomas, L., Schiller, J., Kalkhof, S., Teresa Pisabarro, M., Beck-Sickinger, A. G., Huster, D. (2013) Investigation of lysine side chain interactions of interleukin-8 with heparin and other glycosaminoglycans studied by a methylation-NMR approach. Glycobiology 23, 1260-1269.
89. Seffouh, A., Milz, F., Przybylski, C., Laguri, C., Oosterhof, A., Bourcier, S., Sadir, R., Dutkowski, E., Daniel, R., van Kuppevelt, T. H., Dierks, T., Lortat-Jacob, H., Vivès, R. R. (2013) HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity. FASEB J. 27, 2431-2439.
90. Safaiyan, F., Lindahl, U., Salmivirta, M. (2000) Structural diversity of N-sulfated heparan sulfate domains: distinct modes of glucuronyl C5 epimerization, iduronic acid 2-O-sulfation, and glucosamine 6-Osulfation. Biochemistry 39, 10823-10830.
91. Murphy, K. J., Merry, C. L., Lyon, M., Thompson, J. E., Roberts, I. S., Gallagher, J. T. (2004) A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase. J. Biol. Chem. 279, 27239-27245.
92. Mizumoto, S., Yamada, S., Sugahara, K. (2015) Molecular interactions between chondroitin-dermatan sulfate and growth factors/receptors/matrix proteins. Curr. Opin. Struct. Biol. 34, 35-42.
93. Ledin, J., Staatz, W., Li, J. P., Götte, M., Selleck, S., Kjellèn, L., Spillmann, D. (2004) Heparan sulfate structure in mice with genetically modified heparan sulfate production. J. Biol. Chem. 279, 42732-42741.
94. Williamson, K. A., Hamilton, A., Reynolds, J. A., Sipos, P., Crocker, I., Stringer, S. E., Alexander, Y. M. (2013) Age-related impairment of endothelial progenitor cell migration correlates with structural alterations of heparan sulfate proteoglycans. Aging Cell 12, 139-147.
95. Feyzi, E., Saldeen, T., Larsson, E., Lindahl, U., Salmivirta, M. (1998) Age-dependent modulation of heparan sulfate structure and function. J. Biol. Chem. 273, 13395-13398.
96. Martinez, P., Denys, A., Delos, M., Sikora, A. S., Carpentier, M., Julien, S., Pestel, J., Allain, F. (2015) Macrophage polarization alters the expression and sulfation pattern of glycosaminoglycans. Glycobiology 25, 502-513.
97. Shi, X., Zaia, J. (2009) Organ-specific heparan sulfate structural phenotypes. J. Biol. Chem. 284, 11806-11814.
98. Shao, C., Shi, X., White, M., Huang, Y., Hartshorn, K., Zaia, J. (2013) Comparative glycomics of leukocyte glycosaminoglycans. FEBS J. 280, 2447-2461.
99. Dennissen, M. A., Jenniskens, G. J., Pieffers, M., Versteeg, E. M., Petitou, M., Veerkamp, J. H., van Kuppevelt, T. H. (2002) Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J. Biol. Chem. 277, 10982-10986.
100. Smits, N. C., Kurup, S., Rops, A. L., ten Dam, G. B., Massuger, L. F., Hafmans, T., Turnbull, J. E., Spillmann, D., Li, J. P., Kennel, S. J., Wall, J. S., Shworak, N. W., Dekhuijzen, P. N., van der Vlag, J., van Kuppevelt, T. H. (2010) The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease. J. Biol. Chem. 285, 41143-41151.
101. Stoler-Barak, L., Moussion, C., Shezen, E., Hatzav, M., Sixt, M., Alon, R. (2014) Blood vessels pattern heparan sulfate gradients between their apical and basolateral aspects. PLoS One 9, e85699.
102. Chevalier, F., Arnaud, D., Henault, E., Guillevic, O., Siñeriz, F., Ponsen, A. C., Papy-Garcia, D., Barritault, D., Letourneur, D., Uzan, G., Meddahi-Pellè, A., Hlawaty, H., Albanese, P. (2015) A fine structural modification of glycosaminoglycans is correlated with the progression of muscle regeneration after ischaemia: towards a matrix-based therapy? Eur. Cell. Mater. 30, 51-68.
103. Suhovskih, A. V., Domanitskaya, N. V., Tsidulko, A. Y., Prudnikova, T. Y., Kashuba, V. I., Grigorieva, E. V. (2015) Tissue-specificity of heparan sulfate biosynthetic machinery in cancer. Cell Adh. Migr., [published online ahead of print June 29, 2015].
104. Kreuger, J., Kjellèn, L. (2012) Heparan sulfate biosynthesis: regulation and variability. J. Histochem. Cytochem. 60, 898-907.
105. Pegeot, M., Sadir, R., Eriksson, I., Kjellèn, L., Simorre, J. P., Gans, P., Lortat-Jacob, H. (2015) Profiling sulfation/epimerization pattern of full-length heparan sulfate by NMR following cell culture 13C-glucose metabolic labeling. Glycobiology 25, 151-156.
106. Prèchoux, A., Halimi, C., Simorre, J. P., Lortat-Jacob, H., Laguri, C. (2015) C5-epimerase and 2-O-sulfotransferase associate in vitro to generate contiguous epimerized and 2-O-sulfated heparan sulfate domains. ACS Chem. Biol. 10, 1064-1071.
107. Celie, J. W., Rutjes, N. W., Keuning, E. D., Soininen, R., Heljasvaara, R., Pihlajaniemi, T., Dräger, A. M., Zweegman, S., Kessler, F. L., Beelen, R. H., Florquin, S., Aten, J., van den Born, J. (2007) Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion. Am. J. Pathol. 170, 1865-1878.
108. Watson, H. A., Holley, R. J., Langford-Smith, K. J., Wilkinson, F. L., van Kuppevelt, T. H., Wynn, R. F., Wraith, J. E., Merry, C. L., Bigger, B. W. (2014) Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I. J. Biol. Chem. 289, 36194-36203.
109. Schenauer, M. R., Yu, Y., Sweeney, M. D., Leary, J. A. (2007) CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides. J. Biol. Chem. 282, 25182-25188.
110. Arungundram, S., Al-Mafraji, K., Asong, J., Leach, F. E., Amster, I. J., Venot, A., Turnbull, J. E., Boons, G. J. (2009) Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies. J. Am. Chem. Soc. 131, 17394-17405.
111. Baráth, M., Hansen, S. U., Dalton, C. E., Jayson, G. C., Miller, G. J., Gardiner, J. M. (2015) Modular synthesis of heparin-related tetra-, hexaand octasaccharides with differential O-6 protections: programming for regiodefined 6-O-modifications. Molecules 20, 6167-6180.
112. Bonnaffè, D. (2011) Bioactive synthetic heparan sulfate and heparin derivatives: from long fragments mimetics to chimeras. C. R. Chim. 14, 59-73.
113. Dilhas, A., Lucas, R., Loureiro-Morais, L., Hersant, Y., Bonnaffè, D. (2008) Mixture synthesis and “charge tagging” based demixing: an efficient strategy for the preparation of heparan sulfate libraries. J. Comb. Chem. 10, 166-169.
114. Lu, L. D., Shie, C. R., Kulkarni, S. S., Pan, G. R., Lu, X. A., Hung, S. C. (2006) Synthesis of 48 disaccharide building blocks for the assembly of a heparin and heparan sulfate oligosaccharide library. Org. Lett. 8, 5995-5998.
115. Zulueta, M. M., Lin, S. Y., Hu, Y. P., Hung, S. C. (2013) Synthetic heparin and heparan sulfate oligosaccharides and their protein interactions. Curr. Opin. Chem. Biol. 17, 1023-1029.
116. Gama, C. I., Tully, S. E., Sotogaku, N., Clark, P. M., Rawat, M., Vaidehi, N., Goddard, W. A., Nishi, A., Hsieh-Wilson, L. C. (2006) Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat. Chem. Biol. 2, 467-473.
117. Griffin, M. E., Hsieh-Wilson, L. C. (2013) Synthetic probes of glycosaminoglycan function. Curr. Opin. Chem. Biol. 17, 1014-1022.
118. Jacquinet, J. C., Lopin-Bon, C. (2015) Stereocontrolled preparation of biotinylated chondroitin sulfate E di-, tetra-, and hexasaccharide conjugates. Carbohydr. Res. 402, 35-43.
119. Jacquinet, J. C., Lopin-Bon, C., Vibert, A. (2009) From polymer to sizedefined oligomers: a highly divergent and stereocontrolled construction of chondroitin sulfate A, C, D, E, K, L, and M oligomers from a single precursor, part 2. Chemistry 15, 9579-9595.
120. Wakao, M., Obata, R., Miyachi, K., Kaitsubata, Y., Kondo, T., Sakami, C., Suda, Y. (2015) Synthesis of a chondroitin sulfate disaccharide library and a GAG-binding protein interaction analysis. Bioorg. Med. Chem. Lett. 25, 1407-1411.
121. Liu, J., Linhardt, R. J. (2014) Chemoenzymatic synthesis of heparan sulfate and heparin. Nat. Prod. Rep. 31, 1676-1685.
122. Chappell, E. P., Liu, J. (2013) Use of biosynthetic enzymes in heparin and heparan sulfate synthesis. Bioorg. Med. Chem. 21, 4786-4792.
123. Liu, R., Xu, Y., Chen, M., Weïwer, M., Zhou, X., Bridges, A. S., DeAngelis, P. L., Zhang, Q., Linhardt, R. J., Liu, J. (2010) Chemoenzymatic design of heparan sulfate oligosaccharides. J. Biol. Chem. 285, 34240-34249.
124. Xu, Y., Wang, Z., Liu, R., Bridges, A. S., Huang, X., Liu, J. (2012) Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach. Glycobiology 22, 96-106.
125. Roy, S., El Hadri, A., Richard, S., Denis, F., Holte, K., Duffner, J., Yu, F., Galcheva-Gargova, Z., Capila, I., Schultes, B., Petitou, M., Kaundinya, G. V. (2014) Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies. J. Med. Chem. 57, 4511-4520.
126. Jayson, G. C., Hansen, S. U., Miller, G. J., Cole, C. L., Rushton, G., Avizienyte, E., Gardiner, J. M. (2015) Synthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology. Chem. Commun. 51, 13846-13849.
127. Feizi, T., Chai, W. (2004) Oligosaccharide microarrays to decipher the glyco code. Nat. Rev. Mol. Cell Biol. 5, 582-588.
128. Fukui, S., Feizi, T., Galustian, C., Lawson, A. M., Chai, W. (2002) Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nat. Biotechnol. 20, 1011-1017.
129. Mercey, E., Sadir, R., Maillart, E., Roget, A., Baleux, F., Lortat-Jacob, H., Livache, T. (2008) Polypyrrole oligosaccharide array and surface plasmon resonance imaging for the measurement of glycosaminoglycan binding interactions. Anal. Chem. 80, 3476-3482.
130. De Paz, J. L., Moseman, E. A., Noti, C., Polito, L., von Andrian, U. H., Seeberger, P. H. (2007) Profiling heparin-chemokine interactions using synthetic tools. ACS Chem. Biol. 2, 735-744.
131. Deshauer, C., Morgan, A. M., Ryan, E. O., Handel, T. M., Prestegard, J. H., Wang, X. (2015) Interactions of the chemokine CCL5/RANTES with medium-sized chondroitin sulfate ligands. Structure 23, 1066-1077.
132. Laguri, C., Sapay, N., Simorre, J. P., Brutscher, B., Imberty, A., Gans, P., Lortat-Jacob, H. (2011) 13C-labeled heparan sulfate analogue as a tool to study protein/heparan sulfate interactions by NMR spectroscopy: application to the CXCL12a chemokine. J. Am. Chem. Soc. 133, 9642-9645.
133. Hirose, J., Kawashima, H., Yoshie, O., Tashiro, K., Miyasaka, M. (2001) Versican interacts with chemokines and modulates cellular responses. J. Biol. Chem. 276, 5228-5234.
134. Hirose, J., Kawashima, H., Swope Willis, M., Springer, T. A., Hasegawa, H., Yoshie, O., Miyasaka, M. (2002) Chondroitin sulfate B exerts its inhibitory effect on secondary lymphoid tissue chemokine (SLC) by binding to the C-terminus of SLC. Biochim. Biophys. Acta 1571, 219-224.
135. Shaw, J. P., Johnson, Z., Borlat, F., Zwahlen, C., Kungl, A., Roulin, K., Harrenga, A., Wells, T. N., Proudfoot, A. E. (2004) The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure 12, 2081-2093.
136. Murphy, J. W., Cho, Y., Sachpatzidis, A., Fan, C., Hodsdon, M. E., Lolis, E. (2007) Structural and functional basis of CXCL12 (stromal cellderived factor-1a) binding to heparin. J. Biol. Chem. 282, 10018-10027.
137. Singh, A., Kett, W. C., Severin, I. C., Agyekum, I., Duan, J., Amster, I. J., Proudfoot, A. E., Coombe, D. R., Woods, R. J. (2015) The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pH. J. Biol. Chem. 290, 15421-15436.
138. Joseph, P. R., Mosier, P. D., Desai, U. R., Rajarathnam, K. (2015) Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions. Biochem. J. 472, 121-133.
139. Wagner, L., Yang, O. O., Garcia-Zepeda, E. A., Ge, Y., Kalams, S. A., Walker, B. D., Pasternack, M. S., Luster, A. D. (1998) Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391, 908-911.
140. Soria, G., Lebel-Haziv, Y., Ehrlich, M., Meshel, T., Suez, A., Avezov, E., Rozenberg, P., Ben-Baruch, A. (2012) Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5’s 40s loop and intracellular glycosaminoglycans. Neoplasia 14, 1-19.
141. Lebel-Haziv, Y., Meshel, T., Soria, G., Yeheskel, A., Mamon, E., Ben-Baruch, A. (2014) Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs. Neoplasia 16, 723-740.
142. Meen, A. J., Øynebråten, I., Reine, T. M., Duelli, A., Svennevig, K., Pejler, G., Jenssen, T., Kolset, S. O. (2011) Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROa/CXCL1. J. Biol. Chem. 286, 2636-2647.
143. Chowers, Y., Lider, O., Schor, H., Barshack, I., Tal, R., Ariel, A., Bar-Meir, S., Cohen, I. R., Cahalon, L. (2001) Disaccharides derived from heparin or heparan sulfate regulate IL-8 and IL-1b secretion by intestinal epithelial cells. Gastroenterology 120, 449-459.
144. Lider, O., Cahalon, L., Gilat, D., Hershkoviz, R., Siegel, D., Margalit, R., Shoseyov, O., Cohen, I. R. (1995) A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase. Proc. Natl. Acad. Sci. U. S. A. 92, 5037-5041.
145. Boldajipour, B., Mahabaleshwar, H., Kardash, E., Reichman-Fried, M., Blaser, H., Minina, S., Wilson, D., Xu, Q., Raz, E. (2008) Control of chemokine-guided cell migration by ligand sequestration. Cell 132, 463-473.
146. Ulvmar, M. H., Werth, K., Braun, A., Kelay, P., Hub, E., Eller, K., Chan, L., Lucas, B., Novitzky-Basso, I., Nakamura, K., Rülicke, T., Nibbs, R. J., Worbs, T., Förster, R., Rot, A. (2014) The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes. Nat. Immunol. 15, 623-630.
147. Mortier, A., Gouwy, M., Van Damme, J., Proost, P. (2011) Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp. Cell Res. 317, 642-654.
148. Starr, A. E., Dufour, A., Maier, J., Overall, C. M. (2012) Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16. J. Biol. Chem. 287, 5848-5860.
149. Struyf, S., Proost, P., Van Damme, J. (2003) Regulation of the immune response by the interaction of chemokines and proteases. Adv. Immunol. 81, 1-44.
150. Wolf, M., Albrecht, S., Märki, C. (2008) Proteolytic processing of chemokines: implications in physiological and pathological conditions. Int. J. Biochem. Cell Biol. 40, 1185-1198.
151. Repnik, U., Starr, A. E., Overall, C. M., Turk, B. (2015) Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines. J. Biol. Chem. 290, 13800-13811.
152. Ellyard, J. I., Simson, L., Bezos, A., Johnston, K., Freeman, C., Parish, C. R. (2007) Eotaxin selectively binds heparin: an interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. J. Biol. Chem. 282, 15238-15247.
153. Sadir, R., Imberty, A., Baleux, F., Lortat-Jacob, H. (2004) Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J. Biol. Chem. 279, 43854-43860.
154. McQuibban, G. A., Butler, G. S., Gong, J. H., Bendall, L., Power, C., Clark-Lewis, I., Overall, C. M. (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503-43508.
155. Li, Q., Park, P. W., Wilson, C. L., Parks, W. C. (2002) Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111, 635-646.
156. Sarris, M., Masson, J. B., Maurin, D., Van der Aa, L. M., Boudinot, P., Lortat-Jacob, H., Herbomel, P. (2012) Inflammatory chemokines direct and restrict leukocyte migration within live tissues as glycan-bound gradients. Curr. Biol. 22, 2375-2382.
157. Weber, M., Hauschild, R., Schwarz, J., Moussion, C., de Vries, I., Legler, D. F., Luther, S. A., Bollenbach, T., Sixt, M. (2013) Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 339, 328-332.
158. Roca-Cusachs, P., Sunyer, R., Trepat, X. (2013) Mechanical guidance of cell migration: lessons from chemotaxis. Curr. Opin. Cell Biol. 25, 543-549.
159. Mouw, J. K., Ou, G., Weaver, V. M. (2014) Extracellular matrix assembly: a multiscale deconstruction. Nat. Rev. Mol. Cell Biol. 15, 771-785.
160. Migliorini, E., Thakar, D., Kühnle, J., Sadir, R., Dyer, D. P., Li, Y., Sun, C., Volkman, B. F., Handel, T. M., Coche-Guerente, L., Fernig, D. G., Lortat-Jacob, H., Richter, R. P. (2015) Cytokines and growth factors cross-link heparan sulfate. Open Biol. 5, 150046.
161. O’Boyle, G., Mellor, P., Kirby, J. A., Ali, S. (2009) Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12. FASEB J. 23, 3906-3916.
162. Sweeney, E. A., Lortat-Jacob, H., Priestley, G. V., Nakamoto, B., Papayannopoulou, T. (2002) Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood 99, 44-51.
163. Di Giacomo, F., Lewandowski, D., Cabannes, E., Nancy-Portebois, V., Petitou, M., Fichelson, S., Romeo, P. H. (2012) Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells. Haematologica 97, 491-499.
164. Tsuboi, K., Hirakawa, J., Seki, E., Imai, Y., Yamaguchi, Y., Fukuda, M., Kawashima, H. (2013) Role of high endothelial venule-expressed heparan sulfate in chemokine presentation and lymphocyte homing. J. Immunol. 191, 448-455.
165. Wang, L., Fuster, M., Sriramarao, P., Esko, J. D. (2005) Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat. Immunol. 6, 902-910.
166. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., Gurtner, G. C. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-864.
167. Yamada, S., Sugahara, K., Ozbek, S. (2011) Evolution of glycosaminoglycans: Comparative biochemical study. Commun. Integr. Biol. 4, 150-158.